UK Markets close in 5 hrs 37 mins

Johnson & Johnson (JNJ)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed price. Currency in USD
Add to watchlist
134.70+1.25 (+0.94%)
At close: 4:00PM EDT
People also watch
PGMRKKOPFEXOM
Full screen
Previous close133.45
Open133.27
Bid132.60 x 100
Ask136.33 x 100
Day's range132.90 - 134.79
52-week range109.32 - 137.08
Volume4,150,284
Avg. volume5,532,522
Market cap361.53B
Beta0.64
PE ratio (TTM)22.64
EPS (TTM)5.95
Earnings date17 Oct 2017
Dividend & yield3.36 (2.52%)
Ex-dividend date2017-08-25
1y target est136.89
Trade prices are not sourced from all markets
  • Associated Press7 hours ago

    AP Top Extended Financial Headlines at 11:19 p.m. EDT

    Iran's new telecommunications minister says Twitter is ready to talk about unblocking access to the microblogging site

  • Associated Press7 hours ago

    AP Top Extended Financial Headlines at 11:19 p.m. EDT

    Iran's new telecommunications minister says Twitter is ready to talk about unblocking access to the microblogging site

  • Massive California verdict expands J&J's talc battlefield
    Reuters12 hours ago

    Massive California verdict expands J&J's talc battlefield

    A massive California verdict in a lawsuit alleging Johnson & Johnson's (JNJ.N) talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said. The $417 million award by California jury to a California resident suggested so-called forum-shopping, in which parties seek to file cases in whichever jurisdictions seem most favorable, may not be the main problem facing J&J as it wrestles with some 4,800 outstanding talc lawsuits. J&J, which denies any link between talc and cancer, said in a statement it would appeal Monday's verdict but declined further comment.

Yahoo is now part of ‘Oath’ and a member of the Verizon family of companies. As of 15 September 2017, we plan to share some user information within our new family. Learn more